Literature DB >> 10079381

Primary endometrioid carcinoma of fallopian tube. Clinicomorphologic study.

J Rabczyński1, P Ziółkowski.   

Abstract

Twenty cases of primary Fallopian tube endometrioid carcinoma (PFTEC) are presented in the paper. This accounts for 42.5% of all histologic forms of primary Fallopian tube carcinoma (PFTC) found in our Department. The youngest patient was 38, and the oldest 68 years (mean: 56 years). Seven patients were nulliparas. Only two cases were bilateral. According to FIGO staging, 13 cases were evaluated as stage I, 4 as II, and 3 as stage III. Due to the histologic grading, 8 tumors were classified as well, 7 as moderately, and 5 as poorly differentiated. In the time of preparation of the manuscript, 12 women were still alive, 2 of them with recurrent disease. The follow-up of patients without recurrence ranged from 4 to 120 months (median: 63). Eight patients had died (survival time: from 4 to 65 months; median: 26). Metastases were found in 8 patients, especially to ovaries. In 14/20 cases of PFTEC various forms of tubal wall invasion were observed. Blood or lymphatic vessels involvement was found in 9 patients. Six of them had died and one is alive with the symptoms of disease. Immunohistochemical detection of the mutant form of p53 protein and oncogene product, c-erbB-2, was studied in 17 cases. Nine patients exhibited simultaneous p53 protein accumulation and c-erbB-2 expression. 2/9 of these patients are alive with recurrent tumors and 4/9 died. Endometrioid carcinoma of the Fallopian tube can be characterized by a tendency to superficial invasion of tubal wall and in a half of the cases by invasion of vessels. The majority of these tumors were diagnosed at an early stage tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10079381     DOI: 10.1053/paor.1999.0061

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  22 in total

1.  Primary carcinoma of the fallopian tube.

Authors:  C Y HU; M L TAYMOR; A T HERTIG
Journal:  Am J Obstet Gynecol       Date:  1950-01       Impact factor: 8.661

2.  Carcinoma of the fallopian tube. A clinical and histopathologic review. The Radiumhemmet series.

Authors:  A.-C. Hellström; C. Silfverswärd; B. Nilsson; F. Pettersson
Journal:  Int J Gynecol Cancer       Date:  1994-11       Impact factor: 3.437

3.  Diffusely infiltrating adenocarcinoma of the endometrium. A subtype with poor prognosis.

Authors:  K R Mittal; K W Barwick
Journal:  Am J Surg Pathol       Date:  1988-10       Impact factor: 6.394

4.  Cisplatin-based combination chemotherapy in carcinoma of the fallopian tube.

Authors:  R R Barakat; S C Rubin; P E Saigo; D Chapman; J L Lewis; W B Jones; T B Hakes; M Markman; B Reichman; W J Hoskins
Journal:  Gynecol Oncol       Date:  1991-08       Impact factor: 5.482

5.  Primary carcinoma of the fallopian tube: a 20-year literature review.

Authors:  A J Nordin
Journal:  Obstet Gynecol Surv       Date:  1994-05       Impact factor: 2.347

6.  Prognostic factors in patients with stage I epithelial ovarian cancer.

Authors:  A J Dembo; M Davy; A E Stenwig; E J Berle; R S Bush; K Kjorstad
Journal:  Obstet Gynecol       Date:  1990-02       Impact factor: 7.661

Review 7.  Primary cancer of the fallopian tube. Report of 26 patients.

Authors:  B Jereczek; J Jassem; A Kobierska
Journal:  Acta Obstet Gynecol Scand       Date:  1996-03       Impact factor: 3.636

8.  Endometrioid carcinoma of the ovary: a retrospective study.

Authors:  J Tidy; W P Mason
Journal:  Br J Obstet Gynaecol       Date:  1988-11

Review 9.  Relative frequency of primary ovarian neoplasms: a 10-year review.

Authors:  P P Koonings; K Campbell; D R Mishell; D A Grimes
Journal:  Obstet Gynecol       Date:  1989-12       Impact factor: 7.661

10.  c-erbB-2 and p53 expression in fallopian tube carcinoma.

Authors:  M Q Lacy; L C Hartmann; G L Keeney; S C Cha; H S Wieand; K C Podratz; P C Roche
Journal:  Cancer       Date:  1995-06-15       Impact factor: 6.860

View more
  2 in total

1.  Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.

Authors:  Lauren Patterson Cobb; Stephanie Gaillard; Yihong Wang; Ie-Ming Shih; Angeles Alvarez Secord
Journal:  Gynecol Oncol Res Pract       Date:  2015-05-12

2.  Clinical and survival analysis of 36 cases of primary fallopian tube carcinoma.

Authors:  Ying Ma; Wei Duan
Journal:  World J Surg Oncol       Date:  2014-10-12       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.